Kezar Life Sciences, Inc. (KZR) has a consensus analyst rating of Hold, based on 7 analysts covering the stock. Of those, 2 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for KZR is $6.00, representing a -18.5% downside from the current price of $7.36. Price targets range from a low of $5.00 to a high of $7.00.
